Geron Corporation Profile Avatar - Palmy Investing

Geron Corporation

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, …

Biotechnology
US, Foster City [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of GERN's Analysis
CIK: 886744 CUSIP: 374163103 ISIN: US3741631036 LEI: - UEI: -
Secondary Listings
GERN has no secondary listings inside our databases.